Locations:
Search
Best practices for reducing toxicities
Additional fine-tuning and recruiting of new patient groups underway
An innovative approach to protecting patients during breast and lung radiation therapy
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival
First prospective study looks at endocrine therapy interruption in premenopausal patients
Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia
Use of tool can change recommendation to add or omit radiation
Impressive progression-free survival observed in phase 2 study
Findings support need for personalized disease management
Advertisement
Advertisement